Pharmacology of Bay g 2821, a long-acting, high-ceiling diuretic
- 1 January 1977
- journal article
- research article
- Published by Informa Healthcare in Current Medical Research and Opinion
- Vol. 4 (8) , 555-563
- https://doi.org/10.1185/03007997709115270
Abstract
Bay g 2821 is a diuretic, from a new class of chemical substances, with both the efficacy of diuretics with a high-ceiling activity, such as furosemide, bumetanide and ethacrynic acid, and the prolonged duration of action of thiazides. Pharmacological investigations showed that Bay g 2821 was more potent than furosemide in dogs but less potent in rats. Bay g 2821 did not differ from furosemide in excretion of electrolytes. Further studies showed that Bay g 2821 had an antihypertensive effect in dogs, spontaneously hpertensive rats, and in rats with artificially-induced renal hypertension. Other pharmacological studies did not reveal any other significant effects.Keywords
This publication has 10 references indexed in Scilit:
- Pharmacokinetics of Bay g 2821 in the dog and in manCurrent Medical Research and Opinion, 1977
- Diuretic action of bumetanide in advanced chronic renal insufficiencyEuropean Journal of Clinical Pharmacology, 1976
- GLC Determination and Urinary Recovery of Bumetanide in Healthy VolunteersJournal of Pharmaceutical Sciences, 1973
- Bumetanide: Potent New "Loop" DiureticBMJ, 1972
- Aminobenzoic acid diuretics. 2. 4-Substituted-3-amino-5-sulfamoylbenzoic acid derivativesJournal of Medicinal Chemistry, 1971
- Zum renalen Wirkungsmechanismus der DiuretikaDeutsche Medizinische Wochenschrift (1946), 1970
- Experimentelle und klinische Untersuchungen mit Ethacrinsäure, einem chemisch neuartigen DiureticumKlinische Wochenschrift, 1964
- Experimentelle Untersuchungen und klinische Erfahrungen mit einem neuen DiuretikumDeutsche Medizinische Wochenschrift (1946), 1963
- RENAL CHANGES IN MALIGNANT HYPERTENSION: EXPERIMENTAL EVIDENCEThe Lancet, 1939
- STUDIES ON EXPERIMENTAL HYPERTENSIONThe Journal of Experimental Medicine, 1934